Irinotraz 40 mg Injection
22,44$
17,50$
Irinotraz 40 mg injection is an effective treatment option for patients battling advanced colorectal cancer, functioning as a topoisomerase inhibitor to disrupt the cancer cell's DNA replication process. This medication can be administered in conjunction with 5-fluorouracil and folinic acid for those who have not undergone prior chemotherapy for their advanced condition. It is essential to monitor patients for potential side effects, including severe allergic reactions and changes in blood counts, as these can occur during treatment. Patients are advised to discuss any pre-existing medical conditions and current medications with their healthcare provider to ensure safe administration. By targeting the cancerous cells at a molecular level, Irinotraz helps to slow tumor growth and improve treatment outcomes. As with any cancer therapy, adherence to the prescribed regimen and regular follow-ups are crucial for maximizing effectiveness. Always consult your oncologist for personalized guidance and to address any concerns during the course of treatment with Irinotraz.
Quantité
Active Pharmaceutical Ingredient
Uses
• Irinotraz 40 mg injection is primarily used in the treatment of various types of cancer, particularly colorectal cancer. It works by interfering with the growth of cancer cells, helping to slow down or stop their spread. This makes it an essential component of combination chemotherapy regimens. Patients receiving Irinotraz 40 mg injection may experience improved outcomes as part of their overall treatment strategy.
• The administration of Irinotraz 40 mg injection is typically carried out in a clinical setting by healthcare professionals. This intravenous delivery ensures that the medication is absorbed efficiently into the bloodstream, maximizing its effectiveness. It is often used alongside other chemotherapy agents to enhance treatment efficacy. The specific combination and duration of therapy will be tailored to each patient's unique cancer profile.
• In addition to colorectal cancer, Irinotraz 40 mg injection may be utilized in the management of other malignancies as determined by the healthcare provider. Its role in combination therapies allows for a more comprehensive approach to cancer treatment, targeting different pathways involved in tumor growth. Regular monitoring and adjustments to the treatment plan may be necessary to optimize the therapeutic benefits of Irinotraz 40 mg injection.
• Irinotraz 40 mg injection is often chosen for its ability to provide a systemic treatment option for patients with advanced or metastatic cancer. By effectively delivering chemotherapy directly into the bloodstream, it helps reach cancer cells throughout the body. This approach is particularly valuable for patients whose cancer has spread beyond the primary site. The use of Irinotraz 40 mg injection can play a critical role in the overall management of complex cancer cases.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irinotraz 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Uses of Irinotraz 40 mg Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Benefits of Irinotraz 40 mg Injection is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irinotraz 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irinotraz 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irinotraz 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Irinotraz 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Irinotraz 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of How Irinotraz 40 mg Injection works therapy.
• Liver: Benefits of Irinotraz 40 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Uses of Irinotraz 40 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Irinotraz 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Benefits of Irinotraz 40 mg Injection has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irinotraz 40 mg, Irinotraz 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Side effects of Irinotraz 40 mg Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irinotraz 40 mg Injection.
• Driving: Irinotraz 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Side effects of Irinotraz 40 mg Injection, and advised not to drive or operate machinery if these symptoms occur.